Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Healthcare Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United... see more

Recent & Breaking News (TSXV:MPH)

Medicure Announces Renewal of its Normal Course Issuer Bid

Canada NewsWire May 30, 2019

Medicure Reports Financial Results for Quarter Ended March 31, 2019

Canada NewsWire May 27, 2019

Medicure Q1 2019 Results and Conference Call Dates

Canada NewsWire May 22, 2019

Medicure Appoints Ms. Manon Harvey to its Board of Directors

Canada NewsWire May 15, 2019

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018

Canada NewsWire April 29, 2019

Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019

Canada NewsWire April 24, 2019

Medicure Provides Update on Release of Holdback Funds from Apicore Sale

PR Newswire February 13, 2019

Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States

Canada NewsWire January 28, 2019

Medicure reports financial results for quarter ended September 30, 2018

Canada NewsWire November 20, 2018

Medicure Files Patent Infringement Action

PR Newswire November 16, 2018

Medicure Q3 2018 Results and Conference Call Dates

PR Newswire November 14, 2018

Medicure Reports Financial Results for Quarter Ended June 30, 2018

Canada NewsWire August 15, 2018

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

Canada NewsWire August 13, 2018

Medicure Q2 2018 Results and Conference Call Dates

Canada NewsWire August 8, 2018

Medicure Reports Financial Results for Quarter Ended March 31, 2018

Canada NewsWire May 23, 2018

Medicure Q1 2018 Results and Conference Call Dates

Canada NewsWire May 17, 2018

Medicure Announces Normal Course Issuer Bid

Canada NewsWire May 17, 2018

IIROC Trading Resumption - MPH

Canada NewsWire May 2, 2018

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017

Canada NewsWire May 1, 2018

IIROC Trading Halt - MPH

Canada NewsWire May 1, 2018